|
PHF3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.284200E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.053600E-01 |
| Normal-vs-Stage2 |
2.770600E-01 |
| Normal-vs-Stage3 |
5.202200E-04 |
| Normal-vs-Stage4 |
5.9095000000009E-05 |
| Stage1-vs-Stage2 |
2.838400E-01 |
| Stage1-vs-Stage3 |
3.825100E-04 |
| Stage1-vs-Stage4 |
4.16600000000544E-05 |
| Stage2-vs-Stage3 |
2.769600E-01 |
| Stage2-vs-Stage4 |
9.641600E-02 |
| Stage3-vs-Stage4 |
3.406200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.232100E-02 |
| Normal-vs-AfricanAmerican |
2.704700E-03 |
| Normal-vs-Asian |
9.660200E-01 |
| Caucasian-vs-AfricanAmerican |
5.520200E-02 |
| Caucasian-vs-Asian |
5.952200E-01 |
| AfricanAmerican-vs-Asian |
1.965360E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.940400E-03 |
| Normal-vs-Female |
2.884000E-01 |
| Male-vs-Female |
1.267350E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.968800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.642400E-01 |
| Normal-vs-Age(61-80Yrs) |
3.137700E-03 |
| Normal-vs-Age(81-100Yrs) |
9.703200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.589600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.411400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.587800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.315600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.348100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.142970E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.746200E-02 |
| Normal-vs-Grade 2 |
9.223800E-01 |
| Normal-vs-Grade 3 |
1.136700E-03 |
| Normal-vs-Grade 4 |
3.96930000001738E-06 |
| Grade 1-vs-Grade 2 |
6.889500E-02 |
| Grade 1-vs-Grade 3 |
4.617100E-04 |
| Grade 1-vs-Grade 4 |
4.11700000000348E-05 |
| Grade 2-vs-Grade 3 |
3.818200E-04 |
| Grade 2-vs-Grade 4 |
1.55929999999804E-05 |
| Grade 3-vs-Grade 4 |
2.193800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.596200E-02 |
| Normal-vs-ccB subtype |
7.5772000000085E-05 |
| ccA subtype-vs-ccB subtype |
3.14000048184937E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.368300E-02 |
| Normal-vs-N1 |
8.006600E-04 |
| N0-vs-N1 |
7.304300E-02 |
|
|
